Biosynthetic steroids (fermentation & biocatalytic API)
Corticosteroid and reproductive-hormone APIs made by mycobacterial fermentation of phytosterol into AD/ADD/9-OHAD precursors, then biocatalytic and semi-synthetic finishing — a globally-offshored manufacturing tier anchored by Olon, Farmabios and Gadea in Europe, Tianjin Tianyao in China, Symbiotec in India and Asymchem's biocatalysis CDMO.
1 · What it gives
Biosynthetic steroids are corticosteroid and reproductive-hormone active pharmaceutical ingredients (APIs) produced by microbial fermentation of phytosterol feedstocks into steroid precursors (androstadienedione/AD, androstadienediol/ADD, 9-hydroxyandrostenedione/9-OHAD), followed by biocatalytic and semi-synthetic finishing into cortisone, hydrocortisone, budesonide, testosterone and progesterone. The manufacture has largely moved offshore from the US to Europe, China and India. Olon partners with Ajinomoto Bio-Pharma Services on cGMP biopharmaceutical manufacturing; Farmabios markets a corticosteroid API list; Gadea Pharma supplies sterile corticoid APIs such as budesonide; Tianjin Tianyao is a leading Chinese corticosteroid API producer; Symbiotec Pharmalab is a vertically integrated steroid-API specialist (IPO 2026); and Asymchem is a biocatalysis CDMO whose enzyme-catalysed routes serve steroid synthesis.
The key directions of biosynthetic steroids are:
- Phytosterol biotransformation (Phytosterol Biotransformation): mycobacterial (Mycobacterium) sidechain cleavage of soya/wood-derived phytosterols into AD, ADD and 9-OHAD steroid precursors — the upstream of every biosynthetic steroid.
- Corticosteroid API manufacture (Corticosteroid API): cortisone, hydrocortisone, budesonide, prednisolone and other adrenal corticoids — Olon, Farmabios, Gadea Pharma, Tianjin Tianyao, Symbiotec.
- Androgen and reproductive-hormone API (Reproductive Steroid): testosterone, progesterone, norgestrel and their precursors for replacement therapy and contraception.
- Biocatalytic CDMO (Biocatalysis): enzyme-catalysed regio- and stereo-selective steroid transformations (17α-hydroxylation, Δ1-dehydrogenation) — Asymchem and CDMO peers.
Sectoral value chain#
[soya / wood phytosterol] ──> [mycobacterial fermentation → AD/ADD/9-OHAD] ──> [biocatalytic + semi-synthetic finishing]
│
(GMP crystallisation, CEP/DMF)
│
▼
[formulation-grade API] <─── [cortisone / testosterone / budesonide] <─────┘
Value chain levels#
| Level | Description | Key inputs/outputs |
|---|---|---|
| Phytosterol Feedstock | soya/wood sterol extraction (β-sitosterol, stigmasterol, campesterol) | In: soya/wood oil. Out: phytosterol. |
| Fermentation / Biotransformation | mycobacterial sidechain cleavage to AD, ADD, 9-OHAD | In: phytosterol, mycobacterium. Out: steroid precursor. |
| Biocatalytic & Semi-synthetic Finishing | enzyme-catalysed hydroxylation/dehydrogenation and chemical steps to final steroid | In: precursor, enzymes. Out: steroid API. |
| API Purification & GMP | crystallisation, impurity control, CEP/DMF filing | In: crude API. Out: GMP API. |
| Formulation-grade Supply | shipment to oral, sterile, topical formulators | In: API, dossier. Out: formulated drug. |
| Supply Security & PV | pharmacopeial compliance, supply-chain resilience, pharmacovigilance | In: field data. Out: quality, supply. |
Cross-cutting technologies of the sector:
- Mycobacterial phytosterol degradation (Phytosterol Biotransformation): mycobacteria selectively cleave the phytosterol sidechain to yield AD/ADD/9-OHAD, the universal precursors that replaced chemical synthesis from diosgenin.
- Biocatalytic stereochemistry (Biocatalysis): enzyme-catalysed 17α-hydroxylation, Δ1-dehydrogenation and 11β-hydroxylation introduce the stereochemistry required for corticoid activity, with higher selectivity than chemical routes.
- Sterile and high-potency API CMC (API CMC): sterile corticoid APIs (Gadea) and high-potency corticosteroid GMP require dedicated particle and containment engineering.
2 · What it replaces 0 · matched by industry
No graded substitution linked yet.
3 · How to implement 6 steps
- 1Phytosterol feedstockFeedstock & raw materialsPhytosterols (β-sitosterol, stigmasterol, campesterol) are extracted from soya or wood-derived tall-oil sterol streams and purified as the carbon feedstock for steroid fermentation.Who can do this step matched automaticallyIndia Glycols (NSE) India✓ GMP 7,500 MT/ industrial scale“India Glycols Limited holds the distinction of being the only green petrochemical company of its kind and is the first and only in the world to have commercialized the production …”BBCA Group 丰原集团 Chinaindustrial scale“Second-generation biomanufacturing (non-food feedstocks): Straw/crop residue-based production of straw mixed sugar and plant-based fulvic acid organic fertilizer; a high-yield …”industrial scale“Recent updates highlight public communications on ethanol myths and the broader role of bio-based feedstocks in India.”Sea6 Energy Indiaindustrial scale“Sea6 Energy (founded 2010, headquartered in Bangalore, India) develops mechanized tropical seaweed farming and converts cultivated seaweed biomass into carbon-negative, sustainable …”
- 2Fermentation and biotransformationFermentation & cultivationStrains & cell linesMycobacterial fermentation selectively cleaves the phytosterol sidechain, producing androstadienedione (AD), androstadienediol (ADD) and 9-hydroxyandrostenedione (9-OHAD) precursors at multi-thousand-tonne scale (Tianjin Tianyao and the Chinese cluster lead globally).Who can do this step matched automatically✓ GMP 500 m3“Technology: microbial fermentation with ~500 m3 fermentation capacity; 15+ patents; developed/upscaled probiotic production technologies.”SyncoZymes (Shanghai) China1,200 tons industrial scale“is a biotechnology company specializing in green pharmaceutical technology, biocatalysis, and synthetic biology.”Fermbox Bio India400 kilolitres industrial scale“Fermbox Bio is an active Bengaluru-based synthetic biology and precision fermentation company founded in 2022 by Subramani Ramachandrappa and Preeti Dharmagoudar.”
- 3Biocatalytic and semi-synthetic finishingEnzyme-catalysed hydroxylations and dehydrogenations (Asymchem) plus targeted chemical steps convert the precursors into hydrocortisone, prednisolone, budesonide, testosterone and progesterone with high regio- and stereo-selectivity.
- 4API purification and GMPPurification & downstreamThe steroid API is crystallised, impurity-profiled and released under cGMP, with EDQM Certificate of Suitability (CEP) and FDA Drug Master File (DMF) dossiers supporting global supply.Who can do this step matched automatically✓ GMP 500 m3“Development of robust, scalable fermentation and downstream processing (production and recovery/yield optimization).”SyncoZymes (Shanghai) China1,200 tons industrial scale“CRO/CDMO and Testing/Quality Research Services: Comprehensive contract research and development, analytical, and quality assessment capabilities with access to NMR, LC-MS, GC-MS, …”ScaleUp Bio Singapore10,000 L pilot scale“Core capabilities span pilot-industrial fermentation and downstream unit operations (centrifugation, TFF, chromatography, solvent extraction, spray/freeze drying) with cGMP …”
- 5Formulation-grade supplyFormulation & blendingThe GMP API is shipped to oral, sterile-inhalation, topical and injectable formulators in Europe, the US and globally, under pharmacopeial (Ph.Eur., USP) specification.Who can do this step matched automatically✓ GMP 500 m3“This is a satellite blending, mixing and formulation facility, located at Vashind near Shahapur and dedicated to the company’s Animal Nutrition business.”India Glycols (NSE) India✓ GMP 7,500 MT/ industrial scale“Recent expansions and new facilities across процесses: MEG production growth (up to 200,000 MTPA), EO purification, ethoxylate, sulphation, formulation plants, and …”Zhejiang NHU Company China✓ GMP industrial scale“Looking ahead, NHU will remain committed to advancing nutrition and health by leveraging its biotechnology, chemical synthesis, and microencapsulation technology platforms.”
- 6Supply security and pharmacovigilanceConcentrated offshore production makes supply-chain resilience and cGMP re-inspection continuous concerns, and post-market pharmacovigilance tracks steroid-product safety across the large generics and branded portfolio.
4 · Who delivers
Matched suppliers (matched automatically)
| SyncoZymes (Shanghai) | China | Producer | active |
| Fufeng Group 阜丰集团 (HKEX 546) | China | Producer | active |
| Sumitomo Chemical | Japan | Producer | active |
| VTR Biotech 溢多利 (SZ 300381) | China | Producer | active |
| Aum Enzymes / Infinita Biotech | India | Producer | active |
| Nagase & Co (incl. Nagase Viita) | Japan | Producer | active |
Leading companies and institutes (from the brief)
| Company / Institute | Country | Key products / platforms | Tech features | Status 2026 |
|---|---|---|---|---|
| Olon | 🇮🇹 Italy | Steroid API / CDMO | Fermentation, Aji Bio partnership | commercial |
| Farmabios | 🇮🇹 Italy | Corticosteroid API portfolio | Adrenal-cortical, reproductive | commercial |
| Gadea Pharma | 🇪🇸 Spain | Budesonide sterile corticoid API | Sterile corticoid, Minakem group | commercial |
| Tianjin Tianyao | 🇨🇳 China | Hydrocortisone, prednisolone API | Phytosterol biotransformation (CN leader) | commercial |
| Symbiotec Pharmalab | 🇮🇳 India | Vertically integrated steroid API | Steroid-API specialist, IPO 2026 | commercial |
| Asymchem | 🇨🇳 China | Biocatalysis CDMO | Enzyme-catalysed steroid synthesis | commercial |
5 · Rules & route to market
United States
The US is the largest consumer of steroid APIs but no longer a major producer: steroid-API manufacture has largely offshored to Europe, China and India, leaving the US tier as buyer/formulator.
offshored manufacture, FDA DMF, supply security#
- Offshored API tier: US pharmaceutical companies source corticosteroid and reproductive-hormone APIs from European (Olon, Farmabios, Gadea), Chinese (Tianjin Tianyao) and Indian (Symbiotec) manufacturers under FDA Drug Master Files, with limited US-based fermentation capacity.
- FDA DMF framework: steroid APIs enter the US supply chain under FDA Drug Master Files and cGMP inspection, with corticosteroid products reviewed as generics and branded drugs under NDA/ANDA.
- Supply security: concentrated offshore steroid-API production has made supply security a recurring US policy concern, especially for hospital-critical corticosteroids.
European Union
Europe hosts three specialist steroid-API manufacturers — Olon, Farmabios and Gadea Pharma — plus the EDQM Certification procedure.
Olon, Farmabios, Gadea, EDQM#
- Olon (Italy): a biopharmaceutical CDMO that in October 2025 announced a partnership with Ajinomoto Bio-Pharma Services, strengthening European cGMP fermentation and API capacity for steroid and other complex APIs.
- Farmabios (Italy): markets a portfolio of corticosteroid APIs, with a long-standing position in adrenal-cortical and reproductive-hormone manufacturing.
- Gadea Pharma (Spain): supplies sterile corticosteroid APIs such as budesonide (oral and respiratory) for inhalation and other sterile applications, under the Minakem group.
- EDQM CEP framework: steroid APIs enter the EU supply chain under European Directorate for the Quality of Medicines (EDQM) Certificates of Suitability (CEP) and central EU medicines regulation under Directive 2001/83/EC.
China
China is the world’s largest steroid-API producer, with Tianjin Tianyao a leading corticosteroid manufacturer and Asymchem a global biocatalysis CDMO.
Tianjin Tianyao, Asymchem, NMPA#
- Tianjin Tianyao (天津天药药业): a leading Chinese corticosteroid API producer, manufacturing hydrocortisone, prednisolone and related adrenal-cortical APIs from phytosterol biotransformation for global supply.
- Asymchem (凯莱英): a biocatalysis CDMO whose enzyme-catalysed routes serve steroid and broader API synthesis, supporting the biocatalytic shift from traditional chemical semi-synthesis.
- Domestic cluster: China’s phytosterol-fermentation cluster (including the Zhejiang Xianju region) is the world’s largest steroid-API manufacturing base, exporting cortisone and reproductive-hormone APIs globally.
- NMPA framework: steroid APIs are produced and exported under NMPA cGMP inspection, with API dossiers filed for FDA/EDQM and other regulators.
6 · Money: tenders & grants
| Grant | Circular innovative advanced materials: facilitating the transition from design to markets (RIA) (Innovative … European Commission · EU | Feb 2, 2027 109 days |
| Grant | Open topic: Using the Circular Cities and Regions Initiative to strengthen urban manufacturing in support of … European Commission · EU | Apr 8, 2027 174 days |
| Grant | Textile circularity through advanced processing and manufacturing technologies and system approaches (IA) … European Commission · EU | Feb 2, 2027 109 days |
| Grant | Towards a Europe of Bioeconomy Places European Commission · EU | Sep 22, 2027 341 days |
7 · Tech stack & innovations
The stack pairs mycobacterial phytosterol fermentation with enzyme-catalysed stereochemical finishing and GMP sterile API crystallisation, replacing older diosgenin-based chemical synthesis.
- Phytosterol biotransformation (Phytosterol Biotransformation):
- Mycobacteria selectively cleave the aliphatic sidechain of β-sitosterol/stigmasterol to yield androstadienedione (AD), androstadienediol (ADD) and 9-hydroxyandrostenedione (9-OHAD) — the universal steroid precursors that anchor the entire biosynthetic-steroid industry.
- Corticosteroid API manufacture (Corticosteroid API):
- Olon, Farmabios, Gadea, Tianjin Tianyao and Symbiotec convert AD/ADD/9-OHAD precursors into hydrocortisone, prednisolone, budesonide and other corticoids via regioselective hydroxylation, with Gadea specialising in sterile inhalation APIs.
- Biocatalytic CDMO (Biocatalysis):
- Asymchem and CDMO peers apply enzyme-catalysed 17α-hydroxylation, Δ1-dehydrogenation and 11β-hydroxylation to introduce corticoid stereochemistry with higher selectivity and lower waste than chemical routes.
- Sterile and high-potency API CMC (API CMC):
- Sterile corticoid APIs (Gadea budesonide) and high-potency corticosteroid GMP require dedicated crystallisation, particle and containment engineering under EDQM CEP and FDA DMF dossiers.
Sources 6 · 0 independent · 6 producer sites
Producers' own sites 6
- Olon producer checked 2026-06-03 · link not kept
- Farmabios producer checked 2026-06-24 · link not kept
- Gadea pharma producer checked 2026-03-17 · link not kept
- Tianjin tianyao producer checked 2026-07-20 · link not kept
- Symbiotec producer checked 2026-04-10 · link not kept
- Asymchem producer checked 2026-07-20 · link not kept